Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade

ABSTRACT:

SUBMITTER: Rwandamuriye F 

PROVIDER: S-EPMC11346538 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature